U.S. Government sides with Bayer over Roundup cancer case

Roundup weedkiller did not have to require cancer warnings, according to the EPA and Justice Department.


President Donald Trump’s EPA and the Justice Department sided with Bayer, the company that bought out Monsanto, arguing that the recent federal appeals court decision, that had sided with a cancer-stricken California man, should reverse their decision making Bayer not liable. 

California resident Edwin Hardeman was diagnosed with non-Hodgkin’s lymphoma back in 2015 after using Roundup, a glyphosate-based pesticide, and decided to sue Bayer holding them responsible for his acquired illness. The federal jury sided in favor of Hardeman and ordered Bayer to pay him roughly $25 million in damages.

According to Reuters, the government said in a friend of the court brief filed on Friday that glyphosate, the weed killer’s active ingredient, is not a carcinogen and as a result, a warning on the label was not required as California state law demands. Bayer argued it would be impossible to comply with the Hardeman verdict, a lawsuit brought under state law, because any warning label would be in conflict with guidance from a federal agency.

Back in April, the EPA had reaffirmed that glyphosate is not a carcinogen saying: they “continue to find that there are no risks to public health when glyphosate is used in accordance with its current label and that glyphosate is not a carcinogen. Environmental advocates, however, say otherwise.

Along with federal support, the company also found support on Wall Street, with its stock at one point rising to 14-month highs of $73.93, a gain of 3.5%, says CBS News


If you liked this article, please donate $5 to keep NationofChange online through November.